Clinical

This channel newsfeed includes clinical content on treating patients or the clinical implications in a variety of cardiac subspecialties and disease states. The channel includes news on cardiac surgery, interventional cardiology, heart failure, electrophysiology, hypertension, structural heart disease, use of pharmaceuticals, and COVID-19.

Cardiologists scramble to prepare for mandatory heart failure payment model
Samuel Jones, MD, reviews some of the biggest concerns about a new Medicare payment model focused on heart failure care that goes live in 2027.
Boston Scientific invests $1.5B in MiRus with option to buy its TAVR business
Boston Scientific has invested heavily in Georgia-based MiRus, a rising name in the competitive TAVR landscape.
FDA clears next-gen contrast management system for the cath lab
The Acist Pro Diagnostic System provides real-time contrast tracking, customizable presets and on-screen troubleshooting.
Thousands of reprocessed EP catheters recalled
Stryker Sustainability Solutions is recalling more than 8,000 reprocessed medical devices. This is a Class II recall, according to the FDA, and these devices should no longer be used to treat patients.
PFA has been a game-changer for heart patients—but there are still risks
Devi Nair, MD, reviewed some of the rare complications clinicians are seeing with PFA.

Samuel Jones, MD, MPH, director of inpatient electrophysiology at the Memorial Hospital, Chattanooga Heart Institute, discusses concerns over new heart failure Medicare Ambulatory Specialty Model payment model that starts on Jan. 1, 2027.

Cardiologists scramble to prepare for mandatory heart failure payment model

Samuel Jones, MD, reviews some of the biggest concerns about a new Medicare payment model focused on heart failure care that goes live in 2027.

Boston Scientific invests $1.5B in MiRus with option to buy its TAVR business

Boston Scientific has invested heavily in Georgia-based MiRus, a rising name in the competitive TAVR landscape.

Acist Pro Diagnostic System from ACIST Medical Systems/Bracco

FDA clears next-gen contrast management system for the cath lab

The Acist Pro Diagnostic System provides real-time contrast tracking, customizable presets and on-screen troubleshooting.

Thousands of reprocessed EP catheters recalled

Stryker Sustainability Solutions is recalling more than 8,000 reprocessed medical devices. This is a Class II recall, according to the FDA, and these devices should no longer be used to treat patients.

Devi Nair, MD, director of electrophysiology and research, St. Bernards Medical Center and Arrhythmia Research Group, spoke with Cardiovascular Business at the Heart Rhythm 2026 meeting in the above video interview. She explained both the explosion of PFA use since the first FDA approvals in 2024, and the recently discovered complications of coronary vessel spasm and hemolysis and how newer PFA technology might address this.

PFA has been a game-changer for heart patients—but there are still risks

Devi Nair, MD, reviewed some of the rare complications clinicians are seeing with PFA.

AI helps spot pancreatic cancer over a year before radiologists can

New radiopharmaceutical achieves remission in difficult-to-treat pancreatic cancer

Researchers are optimistic about the treatment's potential, as more options for pancreatic cancer are "urgently needed."

Blood pressure drug recalled after failed test

Nearly 700 bottles of a popular ACE inhibitor are being recalled after it failed an Organic Impurities Test. The drug was manufactured in India and then distributed by New Jersey-based Rising Pharma Holdings.

Cardiac amyloidosis on nuclear imaging of the heart using 11C-PiB PET/CT. Image courtesy of RSNA

Cardiac amyloidosis in the spotlight at Heart Failure 2026

Cardiac amyloidosis continues to get more and more attention at cardiology meetings. At Heart Failure 2026 in Spain, it was the topic of multiple studies, including one on the benefits of acoramidis.